peptide-research
3 articles tagged with ‘peptide-research’
Leuprolide Acetate's Key Role in Reproductive Disorders
Leuprolide acetate acts as a synthetic GnRH agonist to treat various reproductive system issues, including prostate cancer and central precocious puberty. It suppresses gonadotropin secretion, reducing testosterone to levels seen after orchiectomy, which helps manage prostate cancer effectively. Research also shows potential benefits in conditions like endometriosis, breast cancer, and even spinal cord recovery.
BPC-157 Gut Health: Gastric Cytoprotection Studies
Research on BPC-157 began with gastric cytoprotection in the early 1990s, led by Sikiric and colleagues at the University of Zagreb. Studies show it protects against ethanol-induced lesions and NSAID damage in rat models, with effects linked to angiogenesis, prostaglandins, nitric oxide, and gut-brain signaling. This body of work highlights its stability for oral use and broad preclinical applications in GI models.
Canada Approves First Generic Semaglutide: Prices and Timeline
Health Canada authorized the first generic injectable semaglutide on April 28, 2026, making Canada the first G7 nation to approve it. This approval promises lower prices, with generics potentially dropping to $112 per pen as more enter the market, compared to the brand price of $320. A study shows that at $100 per month, nearly six times more Canadians would consider these treatments versus $400 per month.